Literature DB >> 21365645

Steps in prostate cancer progression that lead to bone metastasis.

Jung-Kang Jin1, Farshid Dayyani, Gary E Gallick.   

Abstract

Prostate cancer is a complex disease in which metastasis to the bone is the main cause of death. Initial stages of metastasis are generally similar to those for most solid tumors; however, the mechanisms that underlie the homing of prostate tumor cells to the bone are not completely understood. Prostate cancer bone metastasis is also a microenvironment-driven disease, involving bidirectional interactions between the tumor and the bone microenvironment. In this review, we discuss the current understanding of the biologic processes and regulatory factors involved in the metastasis of prostate cancer cells, and their specific properties that promote growth in bone. Although many of these processes still need to be fully elucidated, a better understanding of the complex tumor/microenvironment interplay is slowly leading to more effective therapies for patients with prostate cancer bone metastases.
Copyright © 2011 UICC.

Entities:  

Mesh:

Year:  2011        PMID: 21365645      PMCID: PMC3082284          DOI: 10.1002/ijc.26024

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  204 in total

1.  Bi-directional interactions of prostate cancer cells and bone marrow endothelial cells in three-dimensional culture.

Authors:  Jeffrey M Barrett; Kathy A Mangold; Tamas Jilling; Karen L Kaul
Journal:  Prostate       Date:  2005-06-15       Impact factor: 4.104

2.  Generalised increase in bone resorption in carcinoma of the prostate.

Authors:  G H Urwin; R C Percival; S Harris; M N Beneton; J L Williams; J A Kanis
Journal:  Br J Urol       Date:  1985-12

3.  Breast cancer cells interact with osteoblasts to support osteoclast formation.

Authors:  R J Thomas; T A Guise; J J Yin; J Elliott; N J Horwood; T J Martin; M T Gillespie
Journal:  Endocrinology       Date:  1999-10       Impact factor: 4.736

4.  The importance of the CXCL12-CXCR4 chemokine ligand-receptor interaction in prostate cancer metastasis.

Authors:  Manit Arya; Hitendra R H Patel; Claire McGurk; Roger Tatoud; Helmut Klocker; John Masters; Magali Williamson
Journal:  J Exp Ther Oncol       Date:  2004-12

5.  Differential expression of laminin 5 (alpha 3 beta 3 gamma 2) by human malignant and normal prostate.

Authors:  J Hao; Y Yang; K M McDaniel; B L Dalkin; A E Cress; R B Nagle
Journal:  Am J Pathol       Date:  1996-10       Impact factor: 4.307

Review 6.  Src family kinases as mediators of endothelial permeability: effects on inflammation and metastasis.

Authors:  M P Kim; S I Park; S Kopetz; G E Gallick
Journal:  Cell Tissue Res       Date:  2008-09-25       Impact factor: 5.249

Review 7.  Role of endothelin-1 in osteoblastic bone metastases.

Authors:  Theresa A Guise; Juan Juan Yin; Khalid S Mohammad
Journal:  Cancer       Date:  2003-02-01       Impact factor: 6.860

8.  Osteoblasts-derived BMP-2 enhances the motility of prostate cancer cells via activation of integrins.

Authors:  Tzu-Hsiu Lai; Yi-Chin Fong; Wen-Mei Fu; Rong-Sen Yang; Chih-Hsin Tang
Journal:  Prostate       Date:  2008-09-01       Impact factor: 4.104

9.  Expression of insulin-like growth factor-1 receptor in local and metastatic prostate cancer.

Authors:  Charles J Ryan; Christopher M Haqq; Jeffrey Simko; Daisuke F Nonaka; June M Chan; Vivian Weinberg; Eric J Small; Ira D Goldfine
Journal:  Urol Oncol       Date:  2007 Mar-Apr       Impact factor: 3.498

Review 10.  The metastatic cascade in prostate cancer.

Authors:  Manit Arya; Simon R Bott; Iqbal S Shergill; Hashim U Ahmed; Magali Williamson; Hiten R Patel
Journal:  Surg Oncol       Date:  2006-12-05       Impact factor: 3.279

View more
  77 in total

Review 1.  Isolated, disseminated and circulating tumour cells in prostate cancer.

Authors:  David Schilling; Tilman Todenhöfer; Jörg Hennenlotter; Christian Schwentner; Tanja Fehm; Arnulf Stenzl
Journal:  Nat Rev Urol       Date:  2012-07-10       Impact factor: 14.432

2.  Genomic profiling screens small molecules of metastatic prostate carcinoma.

Authors:  Axiang Xu; Shengkun Sun
Journal:  Oncol Lett       Date:  2015-07-08       Impact factor: 2.967

3.  [68Ga]PSMA-HBED-CC Uptake in Osteolytic, Osteoblastic, and Bone Marrow Metastases of Prostate Cancer Patients.

Authors:  Jan-Carlo Janssen; Nadine Woythal; Sebastian Meißner; Vikas Prasad; Winfried Brenner; Gerd Diederichs; Bernd Hamm; Marcus R Makowski
Journal:  Mol Imaging Biol       Date:  2017-12       Impact factor: 3.488

Review 4.  Galectin-3 in bone tumor microenvironment: a beacon for individual skeletal metastasis management.

Authors:  Kosei Nakajima; Dong Hyo Kho; Takashi Yanagawa; Melissa Zimel; Elisabeth Heath; Victor Hogan; Avraham Raz
Journal:  Cancer Metastasis Rev       Date:  2016-06       Impact factor: 9.264

Review 5.  The Role of the Microenvironment in Prostate Cancer-Associated Bone Disease.

Authors:  Christina J Turner; Claire M Edwards
Journal:  Curr Osteoporos Rep       Date:  2016-10       Impact factor: 5.096

6.  Tenascin-C and Integrin α9 Mediate Interactions of Prostate Cancer with the Bone Microenvironment.

Authors:  Rebeca San Martin; Ravi Pathak; Antrix Jain; Sung Yun Jung; Susan G Hilsenbeck; María C Piña-Barba; Andrew G Sikora; Kenneth J Pienta; David R Rowley
Journal:  Cancer Res       Date:  2017-09-15       Impact factor: 12.701

Review 7.  Where Hematopoietic Stem Cells Live: The Bone Marrow Niche.

Authors:  Krzysztof Szade; Gunsagar S Gulati; Charles K F Chan; Kevin S Kao; Masanori Miyanishi; Kristopher D Marjon; Rahul Sinha; Benson M George; James Y Chen; Irving L Weissman
Journal:  Antioxid Redox Signal       Date:  2018-01-09       Impact factor: 8.401

8.  The IGR-CaP1 xenograft model recapitulates mixed osteolytic/blastic bone lesions observed in metastatic prostate cancer.

Authors:  Nader Al Nakouzi; Olivia Bawa; Alain Le Pape; Stéphanie Lerondel; Catherine Gaudin; Paule Opolon; Patrick Gonin; Karim Fizazi; Anne Chauchereau
Journal:  Neoplasia       Date:  2012-05       Impact factor: 5.715

9.  Prostate-specific antigen screening for prostate cancer: benefits for patients with highly aggressive prostate cancer.

Authors:  Hui-Jie Jia; Yang Li; Jin-Guo Wang; Ling Zhang; Hai-Tao Zhang; Xue-Jian Zhao; Masaaki Kuwahara
Journal:  Asian J Androl       Date:  2013-01-21       Impact factor: 3.285

10.  METTL3 enhances cell adhesion through stabilizing integrin β1 mRNA via an m6A-HuR-dependent mechanism in prostatic carcinoma.

Authors:  Ermao Li; Bo Wei; Xiaolan Wang; Ran Kang
Journal:  Am J Cancer Res       Date:  2020-03-01       Impact factor: 6.166

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.